Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.
<h4>Objectives</h4>Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a...
Main Authors: | Nobuhisa Ishiguro, Rikako Sato, Toshihiko Mori, Hiroshi Tanaka, Mitsuo Narita, Takashi Nagano, Masato Owaku, Kensuke Miyajima, Atsushi Manabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0258694 |
Similar Items
-
Evaluation of a novel immunochromatographic assay using silver amplification technology for detection of Mycoplasma pneumoniae from throat swab samples in pediatric patients
by: Ishiguro Nobuhisa, et al.
Published: (2021-06-01) -
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
by: Nobuhisa Ishiguro, et al.
Published: (2017-01-01) -
An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report
by: Munehiro Matsumoto, et al.
Published: (2019-02-01) -
Macrolide-Resistant Mycoplasma pneumoniae, United States
by: Xiaotian Zheng, et al.
Published: (2015-08-01) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
by: Gerald L. Murray, et al.
Published: (2017-05-01)